The VanEck Biotech ETF (BBH) provides market-cap-weighted exposure to leading U.S.-listed biotechnology firms.

"Drug development takes persistence and resilience, and that's what our team knew," said CEO Casey Lynch.

A large manufacturing facility for gene therapies in Durham is swapping tenants. Join TBJ for our 33rd annual Fast 50 Awards ...

A California scientist and former magician who claimed he had discovered the cure for HIV has been found guilty of ...

Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. Something unusual is happening with biotech stocks: ...

According to a filing with the Securities and Exchange Commission on Monday, Destiny Wealth Partners reduced its holding in ...

The micro-cap biotech stock Spruce Biosciences had its best day ever after the FDA granted its rare-disease drug a ...

The U.S., once the undisputed leader in pharmaceutical innovation, risks losing its competitive edge unless decisive action ...

A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...

Sutro Biopharma was once worth $1 billion, another Bay Area biotech company with deep coffers and a novel research plan. And ...

What's Sheel Biotech Ltd share price today. Get Sheel Biotech Ltd latest news on BSE/NSE stock price live updates, Sheel Biotech Ltd financial results and overview, Sheel Biotech Ltd stock price ...

I stand here today not only as a widow, but as the mother of seven children whose lives were shattered the night Gregg was ...